312955-00-3 Usage
Uses
Used in Pharmaceutical Development:
ANTI-7-BROMO-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE is used as a building block in the synthesis of novel biologically active molecules and pharmaceuticals, due to its unique structure and potential to target neurological or psychiatric conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, ANTI-7-BROMO-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE serves as a valuable compound for research and development, potentially leading to the discovery of new drugs with specific therapeutic properties.
Used in Drug Discovery:
ANTI-7-BROMO-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE is utilized in drug discovery processes to explore its potential as a precursor or component in the creation of new medications, particularly those aimed at treating neurological or psychiatric disorders.
Used in Chemical Synthesis:
ANTI-7-BROMO-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE is employed in chemical synthesis to produce a variety of related compounds, which may possess different or enhanced properties for use in various applications, including pharmaceuticals and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 312955-00-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,2,9,5 and 5 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 312955-00:
(8*3)+(7*1)+(6*2)+(5*9)+(4*5)+(3*5)+(2*0)+(1*0)=123
123 % 10 = 3
So 312955-00-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H16BrN/c14-13-11-6-7-12(13)15(9-11)8-10-4-2-1-3-5-10/h1-5,11-13H,6-9H2
312955-00-3Relevant articles and documents
7-Substituted 2-Azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn- and anti-Isoepiboxidine
Malpass, John R.,White, Richard
, p. 5328 - 5334 (2007/10/03)
Neighboring group participation by the 2-nitrogen in anti-7-bromo-2-benzyl- 2-azabicyclo[2.2.1]heptane allows ready nucleophilic substitution at the 7-position by C, N, O, and halogen nucleophiles and opens the way to a range of novel 7-substituted 2-azab
7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist
-
, (2008/06/13)
The present invention relates to muscarinic receptor modulators, specifically, 7-oxo-2-azabicyclo[2.2.1]heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, particularly schizophrenia or schizophreniform conditions, mania, pain, bipolar disorder, depression, sleeping disorders, epilepsy, gastrointestinal motility disorders, urinary incontinence, and cognition enhancement.
